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De Novo Synthesis of Plant Natural 
Products in Yeast
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Abstract
Plant natural products possess versatile biological activities including antiviral, 
anticancer and hepatoprotective activities, which are widely used in pharmaceutical 
and many other health-related fields. However, current production of such com-
pounds relies on plant culture and extraction, which brings about severe concerns 
for environmental, ecological and amount of agricultural lands used. With the 
increasing awareness of environmental sustainability and shortage of lands, yeasts 
are engineered to produce natural products, for its inherent advantages such as the 
robustness, safety and sufficient supply of precursors. This chapter focused on the 
recent progress of yeast as a platform for the biosynthesis of plant natural products.
Keywords: natural products, flavonoids, alkaloids, terpenoids, terpenoids saponins, 
biomanufacturing, heterogeneous synthesis, yeast
1. Introduction
Plant natural products were a kind of active compounds including flavonoids, 
alkaloids, terpenoids and saponins etc. As the main composition of plants second-
ary metabolites, these compounds play an important role in plant communication 
and defensing, so these compounds have been widely used as herbicide and pesti-
cide in the agricultural industry [1]. For example, oleanane saponins isolated from 
Bellis sylvestris exhibit strong phytotoxic activity against Aegilops geniculate, and 
saponins from alfalfa can cause a decrease of food metabolized by Tenebrio molitor 
[2]. These compounds were also the major bioactive constituents of some tradi-
tional herbal medicines, such as ginsenosides from ginseng and glycyrrhizin from 
licorice. In addition, some natural products possess special flavors. For instance, 
camphor alcohol has distinctive aroma, while glycyrrhetinic acid monoglucuro-
nide and mogroside V have a strong sweetness which are approximately 941-fold 
and 300-fold of sucrose, respectively [3]. These sweet tasting compounds have 
been widely used in the food industries for weight loss. As a kind of amphiphilic 
compounds, saponins can also act as robust foaming agent in aqueous solutions. 
Based on this trait potential, they have been explored in the cosmetics and detergent 
industries.
Currently, the production of natural products are mainly based on extraction 
from plants, which is a low yield, time consuming, labor intensive and environ-
ment unfriendly supply way [4]. The inefficient approach could not match the huge 
demands of market, and further limit the application of these compounds in the 
pharmaceutical, agricultural, food, cosmetic and detergent industries. Thus, devel-
oping novel approaches are of great significance to replace the traditional method.
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Producing natural products via microorganism cell factories turned out to be 
a promising solution. Compared with plants, microbes exhibit many advantages, 
including fast growing, land saving and controllable. Yeast especially Saccharomyces 
cerevisiae (S. cerevisiae) has become a widely used host for producing these products 
because of its similar intracellular structure with plant cells, such as the inherent 
endomembrane system for microsomal enzymes to stand on. Moreover, the gener-
ally recognized as safe (GRAS) yeast as a robust industrial strain is widely used in 
food and alcohol production and has a clear genetic background. Typically, nearly 
25 g/L artemisinic acid has been produced in S. cerevisiae, which indicated that pro-
ducing natural products by yeast is a potential approach to substitute the traditional 
supply way.
In this chapter, we systematically illustrate the decoded biosynthetic pathway 
of flavonoids, alkaloids, terpenoids and terpenoids saponins assisted by yeast. 
Then briefly summarize the progress of yeast to produce plant natural products. 
Furthermore, novel strategies and tools used to boost their production were 
discussed.
2. Synthetic pathways of natural products
Flavonoids and alkaloids are usually derived from the shikimate pathway, which 
exists in prokaryotic, eukaryotic, and archaeal microorganisms. The synthesis 
pathway start from the stereo-specific condensation catalyzed by 3-deoxy-Dara-
bino-heptulosonate-7-phosphate synthase to generate 3-deoxy-Darabino-heptu-
losonate-7-phosphate (DAHP), which is further catalyzed to form chorismate a 
common precursor for various aromatic compounds, including aromatic amino 
acids, then these aromatic compound will be converted to flavonoids and alkaloids 
Figure 1(a).
Terpenes and saponins are usually synthesized from the common five-carbon 
building blocks, 3-isopentenyl pyrophosphate (IPP) and dimethylallyl pyro-
phosphate (DMAPP), which are synthesized through mevalonic acid (MVA) or 
2-C-methyl-D-erythritol 4-phosphate (MEP) pathway [5]. These five-carbon units 
are condensed to geranyl pyrophosphate (GPP), geranylgeranyl pyrophosphate 
(GGPP), and farnesyl pyrophosphate (FPP). These precursors are then diverted 
to specialized terpenes by terpene synthases. GPP is converted to monoterpene by 
Figure 1. 
(a) Scheme for flavonoid and alkaloid biosynthetic pathways. (b) Scheme for terpene and saponins 
biosynthetic pathways.
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monoterpene synthases, GGPP were used to synthesize diterpenes which can be 
further converted to tretaterpenes, and FPP is the precursor for triterpenes which 
can be converted to saponins by UGTs Figure 1(b).
In order to produce flavonoids, alkaloids, monoterpene, diterpene and tretater-
pene heterogeneously, E. coli is widely used for enzyme identification, because 
of its ease genetic manipulations, whereas the yeast platform was mostly used in 
triterpene synthesis for its endogenous 2,3-oxidosqualene supplement and inner 
membrane structure for membrane located plant CYP450 to stand on, which is 
intensively used and studied in natural products synthesis.
During triterpenoids synthesis, FPP is condensed to 2,3-oxidosqualene, which is 
subsequently cyclized to polycyclic triterpenoid skeletons by oxidosqualene cyclases 
(OSCs). These molecules are oxidized by CYP450s forming aglycones, which are 
further glycosylated to triterpenoid saponins by UGTs.
Cyclization of 2,3-oxidosqualene by OSCs, was the first step in triterpenoid bio-
synthesis. Because of the efficient 2,3-oxidosqualene supplement, most OSCs was 
verified by directly expressing in yeast [6]. Plants OSCs always possess promiscuous 
activities, and could cyclize 2,3-oxidosqualene to different conformations simulta-
neously. For example, amyrin synthase from Glycyrrhiza uralensis can produce not 
only α-amyrin but also β-amyrin [7]. Due to the multiple-activity of OSCs, more 
than 100 kinds of triterpenoid skeletons could be generated during cyclization. This 
was considered as a part of plant defense, for many defensive substances could be 
produced by one process, which can alleviate the metabolic burden of the plants. 
However, the promiscuity of OSCs would lead to undesired structural analogue [8].
The triterpenoid skeletons could be further oxidized by CYP450s, introducing 
active groups such as hydroxyl, carboxyl or epoxy groups [9]. The CYP450s decod-
ing process was complicated, for the identification of CYP450s need much chemi-
cal and bioinformatics information, and the membrane located plant CYP450s is 
hard to express in E. coli. Hence, S. cerevisiae together with chromatography mass 
spectrum and NMR play an important role in the decoding of plant biosynthetic 
pathways involving CYP450s especially for the biosynthesis of triterpenoids and 
their saponins. To date, 48 CYP450s have been identified involved in triterpenoid 
saponins biosynthesis. They were summarized in Table 1.
No. Name Accession 
number
Plant species Substrate Loci
1 CYP51H10 ABG88965.1 Avena strigosa β-amyrin C-12, 
13, 
16β
2 CYP71D353 AHB62239.1 Lotus japonicus lupeol C-20
3 CYP72A61v2 BAL45199.1 Medicago truncatula 24-OH-β-amyrin C-23
4 CYP72A63 BAL45200.1 Medicago truncatula β-amyrin C-30
5 CYP72A67 ABC59075.1 Medicago truncatula oleanolic acid C-2
6 CYP72A68v2 BAL45204.1 Medicago truncatula oleanolic acid C-25
7 CYP72A69 BAW35014.1 Glycine max β-amyrin C-21
8 CYP72A154 BAL45207.1 Glycyrrhiza uralensis β-amyrin C-30
9 CYP87D16 AHF22090.1 Maesa lanceolata β-amyrin C-16α
10 CYP88D6 AQQ13664.1 Glycyrrhiza uralensis β-amyrin C-11
11 CYP93E1 BAE94181.1 Glycine max β-amyrin C-24
12 CYP93E2 ABC59085.1 Medicago truncatula β-amyrin C-24
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No. Name Accession 
number
Plant species Substrate Loci
13 CYP93E3 BAG68930.1 Glycyrrhiza uralensis β-amyrin C-24
14 CYP93E4 AIN25416.1 Arachis hypogaea β-amyrin C-24
15 CYP93E5 AIN25417.1 Cicer arietinum β-amyrin C-24
16 CYP93E6 AIN25418.1 Glycyrrhiza glabra β-amyrin C-24
17 CYP93E7 AIN25419.1 Lens culinaris β-amyrin C-24
18 CYP93E8 AIN25420.1 Pisum sativum β-amyrin C-24
19 CYP93E9 AIN25421.1 Phaseolus vulgaris β-amyrin C-24
20 CYP716A12 ABC59076.1 Medicago truncatula α-amyrin, 
β-amyrin, lupeol
C-28
21 CYP716A14v2 AHF22083.1 Artemisia annua α-amyrin, β-amyrin C-3
22 CYP716A15 BAJ84106.1 Vitis vinifera α-amyrin, 
β-amyrin, lupeol
C-28
23 CYP716A17 BAJ84107.1 Vitis vinifera α-amyrin, 
β-amyrin, lupeol
C-28
24 CYP716A44 – Solanum 
lycopersicum
α-amyrin, β-amyrin C-28
25 CYP716A46 – Solanum 
lycopersicum
α-amyrin, β-amyrin C-28
26 CYP716A47 AEY75213.1 Panax ginseng dammarenediol-II C-12
27 CYP716A52v2 AFO63032.1 Panax ginseng β-amyrin C-28
28 CYP716A53v2 AFO63031.1 Panax ginseng dammarenediol-II C-20
29 CYP716A75 AHF22088.1 Maesa lanceolata β-amyrin C-28
30 CYP716A78 ANY30853.1 Chenopodium quinoa α-amyrin, 
β-amyrin, lupeol
C-28
31 CYP716A79 ANY30854.1 Chenopodium quinoa α-amyrin, 
β-amyrin, lupeol
C-28
32 CYP716A80 ALR73782.1 Barbarea vulgaris α-amyrin, 
β-amyrin, lupeol
C-28
33 CYP716A81 ALR73781.1 Barbarea vulgaris α-amyrin, 
β-amyrin, lupeol
C-28
34 CYP716A83 AOG74832.1 Centella asiatica β-amyrin C-28
35 CYP716A86 AOG74831.1 Centella asiatica β-amyrin C-28
36 CYP716A140 AOG74836.1 Platycodon 
grandiflorus
β-amyrin, 
24-OH-β-amyrin
C-28
37 CYP716A141 AOG74838.1 Platycodon 
grandiflorus
β-amyrin, 
24-OH-β-amyrin
C-28
38 CYP716A180 – Betula platyphylla lupeol C-28
39 CYP716A244 APZ88353.1 Eleutherococcus 
senticosus
β-amyrin C-28
40 CYP716A254 – Anemone flaccida β-amyrin C-28
41 CYP716AL1 AEX07773.1 Catharanthus roseus α-amyrin, 
β-amyrin, lupeol
C-28
42 CYP716C11 AOG74835.1 Centella asiatica oleanolic acid C-2
43 CYP716E41 AOG74834.1 Centella asiatica maslinic acid C-6
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Glycosylation is the last step of triterpenoid saponins biosynthesis that links 
hydrophilic sugar moieties to the hydrophobic aglycone by UGTs. By glycosylation, 
various monosaccharide units (including glucose, glucuronic acid, galactose, 
 rhamnose, xylose and arabinose, etc.) could be linked to aglycone at the posi-
tions C-3, C-28, C-4, C-16, C-20, C-21, C-22 and/or C-23. The introduced of 
sugar  moieties could improve triterpenoid saponins bioactivities. In view of the 
 tremendous amounts of UGTs in plants, more than 120 genes encoding family 1 
UGTs have been identified in Arabidopsis thaliana genome [10]. However, Decoding 
the specific UGT involved in target triterpenoid saponins biosynthesis was very 
difficult. So far, only 23 UGTs have been identified, which involved in triterpenoid 
saponins  biosynthesis. They were summarized in Table 2.
No. Name Accession 
number
Plant species Substrate Loci
44 CYP716E22 – Solanum 
lycopersicum
α-amyrin, β-amyrin C-6
45 CYP716S5 AOG74839.1 Platycodon 
grandiflorus
β-amyrin, oleanolic 
acid
C-12, 
13
46 CYP716Y1 AHF45909.1 Bupleurum falcatum α-amyrin, β-amyrin C-16α
47 CYP716A1 AED94045.1 Arabidopsis thaliana β-amyrin C-28
48 CYP716A2 BAU61505.1 Arabidopsis thaliana α-amyrin C-22
Table 1. 
Overview of plant CYP450s in triterpenoid saponins biosynthesis.
No. Name Accession 
number
Plant species Substrate Loci
1 UGT71G1 AAW56092.1 Medicago 
truncatula
Medicagenic acid 
UDP- glucose
C-3, 
28
2 UGT73AD1 ALD84259.1 Centella asiatica Asiatic acid, Madecassic 
acid UDP- glucose
C-28
3 UGT73AE1 AJT58578.1 Carthamus 
tinctorius
Glycyrrhetinic acid 
UDP- glucose
C-3
4 UGT73AH1 AUR26623.1 Centella asiatica Asiatic Acid UDP- glucose C-28
5 UGT73C10 AFN26666.1 Barbarea vulgaris Hederagenin, Oleanolic 
acid UDP- glucose
C-3
6 UGT73C11 AFN26667.1 Barbarea vulgaris Glycyrrhetinic 
acid, Oleanolic acid 
UDP- glucose
C-3
7 UGT73C12 AFN26668.1 Barbarea vulgaris Hederagenin, Oleanolic 
acid UDP- glucose
C-3
8 UGT73C13 AFN26669.1 Barbarea vulgaris Hederagenin, Oleanolic 
acid UDP-glucose
C-3
9 UGT73F2 BAM29362.1 Glycine max Saponin A0-gα UDP-xylose C-22
10 UGT73F3 ACT34898.1 Medicago 
truncatula
Hederagenin UDP- glucose C-28
11 UGT73F4 BAM29363.1 Glycine max Saponin A0-gα UDP-xylose C-22
12 UGT73F17 AXS75258. Glycyrrhiza 
uralensis
Glycyrrhizin UDP-glucose C-30
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3. Biosynthesis of natural products in yeast
3.1 Biosynthesis of flavonoids in yeast
Flavonoids are among the most extensively investigated natural products, which 
could be divided into several subgroups, including common flavonoids (e.g., galan-
gin, eriodictyol, catechin, quercetin, luteolin, myricetin and cyanidin), isoflavonoids 
(e.g., genistein) and neoflavonoids (e.g., calophyllolide, isodispar B). Due to their 
physiological activity and decoded synthesis pathways, the heterologous biosynthesis 
of flavonoids and their derivatives, have been extensively studied in microbial hosts 
mostly in E. coli. However, high-level flavonoids could also be produced by yeast [11].
Based on yeast platform, 531 mg/L resveratrol production was achieved via 
the tyrosine pathway directly using glucose and ethanol as substrate in fed-batch 
fermentation. Through the subsequent pull-push-block strain engineering strategy, 
more resveratrol production formed via the phenylalanine pathway increased up to 
800 mg/L directly from glucose which was the highest titer of resveratrol up to now.
The co-culture system was also developed for flavonoids production. In the 
collaboration system of E. coli and yeast to produce naringenin, E. coli provides pre-
cursors tyrosine and acetate for yeast to produce naringenin, and finally 21.16 mg/L 
naringenin was obtained from xylose.
No. Name Accession 
number
Plant species Substrate Loci
13 UGT73K1 AAW56091.1 Medicago 
truncatula
Hederagenin, 
Soyasapogenols B and E 
UDP-glucose
C-3, 
28
14 UGT74AE2 – Panax 
Quinquefolium
Protopanaxadiol 
UDP-glucose
C-3
15 UGT74M1 ABK76266.1 Vaccaria 
hispanica
Gypsogenic acid 
UDP-glucose
C-28
16 UGT94Q2 – Panax 
Quinquefolium
Ginsenoside Rh2 
UDP-glucose
C-3
17 UGTPg1 – Panax ginseng Protopanaxadiol 
UDP-glucose
C-3
18 UGTPg100 – Panax ginseng Ginsenoside RF1, 
Protopanaxatriol 
UDP-glucose
C-6
19 UGTPg101 – Panax ginseng Ginsenoside RF1, 
Protopanaxatriol 
UDP-glucose
C-6, 
20
20 Pg3-O-UGT1 – Panax 
quinquefolius
Protopanaxadiol 
UDP-glucose
C-3
21 GmSGT2 BAI99584.1 Glycine max Soyasapogenol B 
monoglucuronide 
UDP-galactose
C-3
22 GmSGT3 BAI99585.1 Glycine max Soyasaponin III 
UDP-rhamnose
C-3
23 UDPG – Panax ginseng Ginsenoside Rd. 
UDP-glucose
Table 2. 
Overview of plant UGTs in triterpenoid saponins biosynthesis.
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3.2 Biosynthesis of alkaloids in yeast
Alkaloid compounds, especially plant-derived benzylisoquinoline alkaloids and 
monoterpene indole alkaloids are considered as a valuable source of pharmaceuticals 
for its anticancer, antiviral and antimalarial activities, et al. In order to replace plant-
extracting method, the reconstruction of plant-derived alkaloid biosynthetic path-
ways in microbes are extensively studied. Though always achieve much lower titers 
than in E. coli, yeast platform was used to produce alkaloid with complex pathway.
By overexpressing 14 known monoterpene indole alkaloid pathway genes and 
an enhancement of secondary metabolism through overexpression of additional 
seven genes and deletion of three genes, strictosidine was produced in yeast with 
a production of 0.53 mg/L. (S)-reticuline (around 80 μg/L), baine (6.4 μg/L) and 
hydrocodone (0.3 μg/L) have been produced in yeast from simple sugars. Indeed, 
the titers was low; However, very recently, the total assembly and optimization 
of the noscapine biosynthetic pathway involving over 30 enzymes in yeast was 
realized, which was very hard to reconstruct in E. coli, and led to a final titer of 
2.2 mg/L noscapine using sugars as substrate [12].
3.3 Biosynthesis of terpenes and saponins in yeast
Similar with flavonoids and alkaloids, some simple terpenoids skeletons such 
as monoterpenoid and diterpenoid, which were produced directly by terpenoid 
synthase, were mostly studied in E. coli for the high activity and easy expression 
of these terpenoid synthase in E. coli. However, in recent years, yeast hosts also 
attracted more and more attention in these fields.
By expressing geraniol synthase from Ocimum basilicum, 0.5 mg/L geraniol was 
obtained in the engineered yeast. The inefficient supplement of precursors GPP 
should be responsible for the low production. To improve the final geraniol con-
centration, an ERG20 mutant was used to block the competitive pathway and the 
production was improved to 5 mg/L. Based on the inherent GPP and the blocking 
of the competitive FPP synthesis pathway, other volatile monoterpenes, includ-
ing sabinene and limonene, were also produced by expressing plant monoterpene 
synthase in yeast host.
Moreover, the heterologous biosynthesis of diterpenoid by yeast also became 
a new trend and gained more and more attention. Through introducing diterpe-
noids synthase and metabolic optimization, several plant diterpenoids including 
taxadiene and miltiradiene were produced in yeast. With the introducing of the 
taxadiene biosynthetic pathways, and the optimization of precursors supplement 
by strengthen the MVA pathway through overexpressing tHMG1 and UPC2-1 
(a global transcription factor of MVA), the taxadiene was successfully produce in 
the engineered yeast and achieved a production of 8.7 mg/L, though the produc-
tion was lower than that produced in E. coli (1 g/L). However, when it involves in 
more complex skeletons, such as ferruginol and carnosic acid which need further 
oxidation by CYP450s, yeast displays the huge potential. The membrane located 
plant CYP450s are hard to functionally expressed in E. coli. By co-expressing 
CYP76AH1 and plant cytochrome P450 reductase (CPR) genes heterogeneously in 
a miltiradiene producing yeast strain, ferruginol was successfully achieved with a 
titer of 10.5 mg/L. Based on ferruginol, carnosic acid, a C20 oxidations products of 
miltiradiene, was produced in yeast by introducing an extra CYP76AK6-8 and these 
compounds still cannot be produced by E. coli.
As an exception, the heterogeneous biosynthesis of triterpenoid and triterpe-
noid saponins were mostly studied in yeast, for the membrane located plant OSC 
and CYP450 are challengeable to correctly express in E. coli. By overexpressing the 
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codon optimized OSC from Glycyrrhiza glabra designated as β-amyrin synthase 
(βAS), Zhang et al. obtained a β-amyrin production as high as 138.8 mg/L in the 
engineered S. cerevisiae Sgib [13]. Through co-expressing the liquorice CYP88D6 
and CYP72A154 with β-amyrin synthase and CPR genes in yeast, glycyrrhetinic 
acid was produced with a titer of about 20 μg/L. To boost the glycyrrhetinic acid 
titer, Zhu et al identified novel CYP450s uni25647 and CYP72A63 with higher activ-
ity than CYP88D6 and CYP72A154 by yeast host. With these two CYP450s and a 
novel liquorice CPR, Zhu et al. reconstructed the GA synthesis pathway in sgib and 
improved the glycyrrhetinic acid titer up to 18.9 mg/L, which is 1000 folds com-
pared with that in the former study [14]. Zhao et al. overexpressed an efficient CPR 
(MtCPR1) gene, and reconstructed the galactose regulatory network by knocking 
out GAL1 and GAL80 while using strong inducible promoters GAL1 and GAL10 to 
operate CYPP450, MtCPR1, ERG1 and ERG9). Finally, 186.1 mg/L oleanic acid was 
achieved in yeast, which is the highest concentration in reported literatures [15]. 
More recently, Yu et al. introduced a high specific α-amyrin synthase in yeast lead-
ing to the production of α-amyrin, β-amyrin and lupeol at a ratio of 86:13:1 with the 
α-amyrin titer of 11.97 mg/L, 5.8-folds of the maximum production reported [16].
Benefit from the yeast hosts, the more complex saponins were also heterolo-
gously synthesized. By expressing Barbarea vulgaris UGT73C11 in a glycyrrhetinic 
acid producing yeast strain, Liu et al. realized the de novo synthesis of glycyrrhet-
inic acid-3-O-monoglucose starting from sample glucose [17]. With the decoding of 
plant biosynthetic pathways, many other triterpenoid saponins have been success-
fully synthesized in yeast factories and the high production of ginsenoside Rh2 
(2.5 g/L) has highlighted the commercial feasibility of this approach.
Panax ginseng is a famous herb medicine widely used in Asia, which possesses 
various pharmaceutical activities including anticancer, anti-inflammatory and anti-
viral activities. These activities are mainly endowed by its triterpenoids saponins, 
known as ginsenosides [18]. Because of their low content and the long culture cycle 
of ginseng, the heterologous biosynthesis of ginsenosides in microbial cell factories 
is drawing more and more attention. To date, various ginsenosides and its aglycones 
have been successfully produced in S. cerevisiae (Figure 2), including protopanaxa-
diol, protopanaxatriol and oleanolic acid, the three main kinds of aglycones, and 
four kinds of ginsenosides, ginsenosides Rh2, Rg3, RF1 and Rh1. In addition, some 
unnatural ginsenosides such as compound K and 3β, 12β-Di-O-Glc-PPD have also 
been synthesized by combination various enzymes from different species.
Figure 2. 
Scheme for ginsenosides biosynthesized in S. cerevisiae. The green arrows represent OSCs, the yellow arrows 
represent CYP450s, the blue arrows represent UGTs.
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Protopanaxadiol (PPD) is an important starting material for the biosynthesis 
of ginsenoside, which is synthesized from 2,3-oxidosqualene by dammarenediol-II 
synthase and CYP450s. Through expressing P. ginseng dammarenediol-II synthase 
(PgDS), P. ginseng CYP716A47 and A. thaliana CYP450 reductase 1 (AtCPR1), PPD 
was firstly produced in S. cerevisiae [19]. Subsequently, the more complex ginsen-
osides aglycone protopanaxatriol (PPT) was produced by engineered yeast carrying 
P. ginseng CYP716A53v2 and AtCPR1 which uses PPD as substrate. By the similar 
strategy of co-expression of P. ginseng β-amyrin synthase (PNY1) CYP716A52v2 
and AtCPR1, oleanolic acid (OA), a oleanane-type pentacyclic triterpene, was 
synthesized in S. cerevisiae [20]. Although these three ginsenoside aglycones had 
been successfully synthesized in yeast, the titer was still too low. A truncated 
version of tHMG1 (3-hydroxyl-3-methylglutaryl-CoA reductase), ERG20 (farnesyl 
diphosphate synthase), ERG9 (squalene synthase) and ERG1 (2,3-oxidosqualene 
synthase) were overexpressed to improve the PPD production in S. cerevisiae. 
Together with a codon optimized P. ginseng CYP716A53v2, the production of PPD 
was increased by 262-fold and up to nearly 1.2 g/L. The efficient supplement of PPD 
made the strain an ideal platform for further tailored ginsenosides biosynthesis 
[21]. By similar strategies, the PPT production was increased by overexpressing 
ERG9, ERG1, tHMG1 and corresponding CYP450 genes with codon optimization.
The widely studied ginsenosides Rh2 and Rg3 which are synthesized from PPD 
have been successfully biosynthesized in S. cerevisiae. By expressing PgDS, CYP450 
system consisting of CYP716A47, AtCPR2 to supply PPD, and the co-expressing of 
PgUGT74AE2 and PgUGT94Q2 for glycosylation of PPD, Rg3 was heterologously 
synthesized in S. cerevisiae. Combine with the approach of replacing the native 
promoter of ERG7 with a methionine-repressible promoter (MET3), the produc-
tion of Rg3 was increased up to 1.3 mg/L. [22] Other type of ginsenosides such as 
RF1 and Rh1 were synthesized through the co-expression of PgDS, CYP716A53v2, 
CYP716A47, PgCPR1 and UGTPg100 (or UGTPg1). The production of RF1 and Rh1 
reached 42.1 and 92.8 mg/L in S. cerevisiae, respectively [23].
It is demonstrated that compound K (CK), generally considered as the metabo-
lite of glycosidases [24], is the main functional form of oral administration of gin-
senosides [25]. By the co-expression of PgDS, AtCPR2, CYP716A47 and UGTPg1, 
CK has already been synthesized in S. cerevisiae. Its production was further 
increased up to 1.4 mg/L by overexpressing tHMG1 and UPC2.1 as well as control-
ling heterogeneous genes via GAL promoters [26]. By combination of tailoring 
enzymes from various species, more unnatural ginsenosides could be synthesized 
in S. cerevisiae. Through the combination of plant PgDS, CYP716A47, AtCPR1 and 
UGT109A1 from B. subtilis, 3β, 12β-Di-O-Glc-PPD was produced in S. cerevisiae. To 
further optimize the production, overexpression of tHMG1 and the fusion expres-
sion PgDS was carried out, and ERG7 (encoding lanosterol synthase) promoter was 
replaced with an antisense one. Through these strategies, the production of 3β,12β-
Di-O-Glc-PPD was increased up to 9.05 mg/L in the engineered S. cerevisiae [27].
Besides ginsenosides, the heterogeneous biosynthesis of other triterpenoids 
saponins with markedly physiological function also attracted much attention. The 
natural sweeter mogroside V from S. grosvenorii, which is nearly 300 times sweeter 
than sucrose, is widely used as a food additive in low-calorie sweet beverages [28]. 
Through analysis of S. grosvenorii transcriptome data and gene mining, the key 
genes involved in mogroside V synthesis including cycloartenol synthase (CAS) 
gene, epoxide hydrolases (EPH) gene, CYP102801, UGT94-289-3 and UGT720-
269-1 have been identified. By introducing these enzymes together with squalene 
synthase (SQS), squalene epoxidase (SQE) and AtCPR1 in S. cerevisiae, mogroside 
V was successfully produced. These advances highlight the possibility to produce 
natural, noncaloric sweetener mogrosides by engineered yeast.
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Saikosaponins are the major pharmaceutical constituents of B. falcatum, an 
important perennial herb widely used in traditional Chinese medicine which exert 
multiple bioactivities [29]. Currently, two saikosaponins aglycones, 16α-hydroxy 
α-amyrin and 16α-hydroxy β-amyrin have been synthesized in engineered S. cerevisiae 
through co-expressing CYP716Y1, AtCTR1, CaDDS (dammarenediol synthase from 
Centella asiatica) or GgbAS (β-amyrin synthase from Glycyrrhiza glabra in S. cerevi-
siae, respectively [30].
Moreover, by overexpressing lycopene synthetic genes from Erwinia uredovora, 
this ungroomed tetraterpene compound was synthesized by the engineered yeast 
strain, with a production of 3.3 mg/g CDW. To boost the lycopene production in 
yeast, Ma et al. overexpressed key genes associated with fatty acid synthesis, TAG 
production, and TAG fatty acyl composition, and deleted FLD1 to increase lipid-
droplet size for more hydrophobic storage space of lycopene, leading to a produc-
tion of 2.37 g/L, which weighed against that produced in E. coli [31]. This indicates 
the potential of yeast to produce simple terpenoid directly synthesized by terpenoid 
synthase.
All these progresses indicate the great potential of yeast for heterologous synthe-
sis of natural products, especially for these with complex molecular structure and 
synthetic pathways such as terpenoids and their saponins. Recently, various kinds 
of terpenoids and saponins were heterologously produced in yeast, but most of 
them had a low final concentration far from to instead of plant extracting methods. 
To boost the production efficiency of engineered yeast strains, various strategies 
need intensively study.
4. Strategies for boosting biosynthesis of terpenoids in yeast
Although various kinds of natural products could be produced by yeast, many 
challenges still remain for this approach. The main bottleneck of building an effi-
cient yeast cell factory was that the biosynthetic pathways are not totally elucidated 
and the poor or disappeared activity of plant enzymes when expressed in yeast. 
Moreover, the destabilization on the native metabolic flux caused by the heteroge-
neous pathways could lead to low cell growth and low final products concentration, 
and the cytotoxicity most of natural products also restrict the use of microbial hosts 
for producing natural products. Strategies and biotools focused on settling such 
issues to accelerate the microbial natural products biosynthesis in yeast host have 
been developed based on omics, metabolic engineering and protein engineering 
(Figure 3).
4.1 Strategies to redesign natural biosynthetic pathways
Unlike some prokaryotic biosynthetic pathway genes, which always locate on 
a gene cluster, the genes involved in triterpenoid saponins biosynthesis always 
distributes among the whole genome in plants. Moreover, the expression of these 
genes generally needs intricate inducible conditions, which increase the difficulty to 
elucidate triterpenoid saponins biosynthetic pathways.
Benefit from the rapid progress of sequencing technology, genome and tran-
scriptome of many medicinal plants have been sequenced, and the information 
has been publicly available online (http://medicinalplantgenomics.msu.edu). The 
analysis of the genome and transcriptome date facilitates the prediction of genes 
involved in the targeted compound biosynthesis. Through the comparison of the 
transcriptome information between plants or tissues with high- and low-production 
of the target compounds, several key genes could be predicted. For example, 
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through comparing the transcriptome data between high- and low-producing 
varieties, the genes including bAS1, CYP716A79 and CYP716A78 that involved 
in quinoa saponins biosynthesis were targeted from Chenopodium quinoa. The 
predicted genes were then functionally identified by expressing in yeast [32]. By 
comparing the transcriptome data between ethyl alcohol and methyl jasmonate 
elicited conditions, key genes involved in maesasaponins biosynthesis including 
bAS, CYP716A75 and CYP87D16 from Maesa lanceolate were targeted and were sub-
sequently identified by expressing in yeast host [33]. Depending on the comparison 
Figure 3. 
Scheme for strategies used to advance biosynthesis of triterpenoid saponins in microbial hosts. (a) Strategies 
to design triterpenoid saponins biosynthetic pathways; (b) Strategies to improve plant enzyme activity in 
microbial hosts; (c) Strategies to enhance metabolic flux in microbial hosts; (d) Strategies to reduce toxicity to 
the hosts.
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of the transcriptome data between varieties with different phenotype, key genes 
involved in target compound biosynthetic pathways can be predicted, and be 
further identified by functionally expressed in yeast. Generally, the expression pat-
terns of genes involved in the same biological process are strongly correlated. Thus, 
genes co-expression analysis was applied to predict the functions of unidentified 
genes. Based on this strategy, CYP716A12, CYP93E2, CYP72A61v2 and CYP72A68v2 
from M. truncatula have been functionally identified [34].
Besides mining enzymes from native host, the application of the substrate-
promiscuous enzymes turned out to be an alternative approach to reconstruct the 
target compounds biosynthetic pathways. For instance, the nonnative substrate-
promiscuous glycosyltransferase Bs-YjiC from B. subtilis 168 was used for the 
synthesis of ginsenoside Rh1 and some unnatural ginsenosides in S. cerevisiae [35]. 
Other substrate-promiscuous enzymes like UDP-glycosyltransferase UGT109A1, 
was also used to produce the unnatural ginsenosides 3β, 12β-Di-O-Glc-PPD, 3β,12β-
Di-O-Glc-PPT, 3β,20S-Di-O-Glc-DM, and 3β-O-Glc-DM.
The low final concentration of the synthesized compounds is always caused by 
the poor enzyme activity on the unnatural substrate. Protein evaluation, which 
could improve the catalytic characteristic involving “substrate specificity” of the 
substrate-promiscuous enzymes has been developed for the specific decoration of 
natural and unnatural substrates. One example is the engineering of the substrate-
promiscuous UDP-glucose sterol glucosyltransferase UGT51 from S. cerevisiae. 
UGT51 can glycosylate a series of structural analogues, including pregnenolone, 
cholesterol, ergosterol, sitosterol, diosgenin, estradiol, PPD and PPT. Because 
of the wide substrate spectrum, UGT51 has been applied for the biosynthesis of 
ginsenosides Rh2 with the co-expression of PgDS, CYP716A47 and AtCPR1 in S. 
cerevisiae. However, only trace amount of Rh2 was synthesized. To improve the 
enzyme activity, a semi-rational design strategy was developed based on the crystal 
structure of UGT51 (PDB code: 5gl5). The best UGT51 mutant gained an 1800-fold 
higher catalytic efficiency (kcat/Km) in converting PPD to ginsenoside Rh2 in vitro 
and the Rh2 production reached up to 300 mg/L in vivo [35]. Using non-native 
promiscuous enzymes to reconstruct the natural products biosynthetic pathways is 
an efficient strategy to achieve the heterogeneous synthesis of triterpenoid saponins 
in yeast, especially for that without integrated illuminated pathways.
4.2 Strategies to improve plant enzyme activity
Plant CYP450s are indispensable enzymes for the C–H bounds oxidation of trit-
erpenoid skeletons. However, heterogeneous expression of plant CYP450s in yeasts 
hosts usually exists problems as low expression level, poor catalytic efficiency or 
even incorrect folding structure. Plant CYP450s involved in triterpenoids synthesis 
are membrane-bound oxidase enzymes, which anchor in the endoplasmic reticu-
lum (ER) of plants cells and requires electrons transferred by CYP450 reductase. 
Although CYP450 is essential for the hydroxylation of C–H bounds and can further 
oxidize the alcohol products to aldehyde and acid, it always shows poor activity on 
such substrates. As a result, it is challenging to establish high-yield triterpenoid 
saponins in yeast cell factories, and improving the plant CYP450s is essential to 
improve the situation. Currently, many strategies have been developed to improve 
the expression level and regulate the pairing efficiency of CPRs to plant CYP450s in 
microbial hosts.
Codon optimization and application of a strong promoter are the most common 
strategies to improve enzyme expression level in heterologous hosts and it is also 
effectively used to improve plant CYP450s expression level in microbial hosts [36]. 
Chimeric protein has been used to correct the folding of plant CYP450s in microbial 
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hosts. As plant CYP450s are anchored in ER membrane, the activity can be 
improved by replacing the native N-terminal sequence with ER-membrane bound 
proteins of yeast to facilitate correctly folding and anchoring. Protein directed evo-
lution was also applied to enhance the activity of plant enzymes. In consideration of 
that the enlargement of ER would provide more room for the ER-located CYP450s 
and CPRs leading to higher protein abundance, a novel ER morphology engineering 
strategy is developed. Through the deletion of PAH1 gene encoding phosphatidic 
acid phosphatase, the ER membranes of S. cerevisiae was tremendously expanded, 
which accelerated the expression of CYP450s including CYP716A12, CYP72A67 
and CYP72A68, and ultimately leading to increased production of triterpenoid 
and triterpenoid saponins. Approaches like codon optimization, Chimeric protein, 
protein directed evolution and ER enlargement have been used to improve CYP450s 
expression level in heterologous hosts.
The pairing efficiency of CYP450s and CPRs plays an important role for the 
catalytic activity of CYP450s. Mining novel CPRs is a straightforward way to 
improve the CYP450 activities as different CPRs has different pairing efficiency 
with CYP450s. For example, the CPR from M. truncatula was proved to be the most 
efficient one pairing with CYP716A12 among all the tested CPRs from G.  uralensis, 
Lotus japonicus and A. thaliana, and boosted OA biosynthesis in yeast [15]. 
Moreover, the co-expression of CYP72A63 and/or uni25647 with GuCPR1 from 
G. uralensis showed higher activities than the co-expression with other CPRs from 
M. truncatula, A. thaliana, or L. japonicus. The using of GuCPR1 resulted in boosted 
GA production in yeast [14]. Besides the using different CPRs, ratios between 
CYP450 and CPR also contribute to the CYP450 activities. Fine-tuning the ratios 
between CYP450 and CPR is an important strategy to improve their pairing effi-
ciency. For example, with the best ratio of 5:9 between CYP716Y1 and CPR1 from 
A. thaliana, the 16-α-hydroxy amyrin production was significantly increased [30]. 
These results indicate that improving the pairing efficiency by efficient CPRs and 
proper pairing ratio between CYP450 and CPR can improve the targeted compound 
production in yeast.
4.3 Strategies to enhance metabolic flux
The plant natural products biosynthetic pathways always include multiple 
steps. When introduced in yeast, the heterogeneous pathways would intensively 
interact with the native metabolic network, by means of competing substrates and 
co-factors as well as metabolites reverse influence. The disturbance will restrict the 
targeted compound production. Therefore, balancing metabolic flux distribution 
between heterologous pathways and native metabolic networks plays an important 
role in promoting the production of targeted compound.
Enhancing the precursors supplement to the targeted pathway is a straightfor-
ward strategy to enhance natural products production. As demonstrated, the five-
carbon building blocks IPP and DMAPP are naturally synthesized through either 
eukaryotic MVA or prokaryotic MEP pathway in microorganisms. The combination 
of MVA and MEP pathways in one host could take advantages of both pathways and 
lead to more efficient precursor supplement for terpenoids. Through introducing 
a heterogeneous MVA pathway, 27.0 g/L amorphadiene was achieved in E. coli. 
Besides, the production of other terpenoids such as valerenadiene (62.0 mg/L), 
isoprene (24.0 g/L), and lycopene (47.0 mg/L) were also successfully increased by 
the synergy of the MEP and the MVA pathway in E. coli. In view of the availability 
of this strategy, the combination of MVA and MEP pathway have been developed 
in yeast. In addition to the cooperation of the MEP and the MVA pathways, taking 
full advantage of precursors synthesized in different organelles was helpful to boost 
Yeasts in Biotechnology
14
the terpenoids producing. By improving the utilization of acetyl-CoA through 
the simultaneously introducing dual MVA pathways located in cytoplasmic and 
mitochondrial of yeast, 2.5 mg/L isoprene was obtained [37]. Moreover, HMG-CoA 
reductase catalyzing the conversion of HMG-CoA to mevalonate is a rate-limiting 
factor of MVA pathway. The HMG-CoA reductase is feedback regulated due to its 
N-term transmembrane sequence, so the truncated version (N-term truncated) 
of HMG-CoA reductase (tHMG1) is intensively used to strengthen the precursor 
supplement. Globe transcriptional regulation by overexpressing UPC2-1, which is 
a global sterol regulatory element to induce sterol biosynthetic genes expression, is 
another effective method to improve the MVA flux globally [38].
Decreasing the metabolic flux of competing pathways is efficient to strengthen 
the flux to targeted pathway. However, in most cases, directly deletion of the enzymes 
involved in the competing could lead to lethality, for many of the genes are essential 
to the hosts. Therefore, decrease the metabolic flux to the competing pathways by 
down-regulation of key enzymes is a proper approach to strengthen the final pro-
duction. Generally, the cellular protein concentration is regulated by transcription, 
RNA degradation, translation and protein degradation. The application of weaker 
promoters is the most commonly used strategy to down-regulate the transcriptional 
level of key genes. To decrease the sterol synthesis and redirect the metabolic flux to 
the β-amyrin synthesis pathway in yeast. ERG7 (lanosterol synthase gene) promoter 
was replaced by a methionine repressible promoter (PMET3). Moreover, in order 
to improve the α-santalene accumulation in yeast, the native promoter of ERG9 
(squalene synthase gene) was replaced by PCRT3, the copper repressible promoter 
and PHXT1, a low concentration glucose repressible promoter which resulted in 
decreased metabolic flux to ergosterol synthesis and increased α-santalene produc-
tion [39]. Recently, dynamic protein degradation was developed to weaken the com-
peting pathways. Depending on the ER-associated protein degradation system, the 
cytosolic proteins can be degraded when attached by a PEST sequence. As a result, 
the strategy of using the G1 cyclin PEST sequence as a degradation degron to label 
the cytosolic term of squalene synthase was developed for the production of trans-
nerolidol. Once labeled by degron, the squalene synthase will be degraded dynami-
cally, resulting in enhanced sesquiterpene trans-nerolidol production. By the similar 
strategy, farnesyl pyrophosphate synthetase was labeled by a designed N-terminal 
degron on the N-terminus, which increased the titer of monoterpene linalool [40].
4.4 Strategies to reduce toxicity to the hosts
Natural products always exhibit cytotoxicity to the microbial hosts, leading to 
decreased cell growth and finally impair the production. In order to solve these 
problems, various strategies were developed including two-stage fermentation, 
pathway compartmentalization and transporters mediated compound secretion. 
In order to alleviate the negative influences on cell growth, the fermentation course 
is divided into two stages. In first fermentation stage, heterogeneous pathway 
keep silence and cells grow fast with precursor accumulated, while in the second 
stage, target pathway would be induced to produce the target compounds [41]. 
In addition to the traditional two-stage fermentation, the organelles including 
mitochondria, peroxisome and vacuole were also used to compartmentalize the 
heterogeneous pathways. Because the integrated membrane structure, these 
organelles are relatively independent from the cytoplasm, which could prevent the 
toxic precursors and products from distributing in cytoplasm to disrupt cell growth. 
Furthermore, subcellular compartmentalization of target biosynthetic pathways 
can concentrate the substrates, intermediates and enzymes in a more narrow 
space, which can improve the reaction efficiency of enzymes. Through locating the 
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amorpha-4,11-diene biosynthetic pathways in the mitochondria of yeast, the amor-
pha-4,11-diene production increased by 63% compared with locating in the cytosol. 
By this strategy, the precursor FPP was restricted in mitochondria by the membrane 
structure, which reduced the loss of FPP. Using similar strategy, the valencene 
biosynthetic pathway was reconstructed into the mitochondria of yeast resulting in 
eight-fold increase of valencene production. Besides the mitochondria, peroxisome 
was also used to compartmentalize the heterogeneous pathways, by introducing the 
lycopene synthesis pathway in peroxisome, lycopene production was improved up 
to 73.9 mg/L in Pichia pastoris [42]. Therefore, subcellular compartmentalization 
was a pioneering strategy to reduce products cytotoxicity to the microbial hosts.
Another strategy to reduce the inner cytotoxicity of natural products is to secrete 
these compounds outside the cell automatically. To achieve this goal, transport-
ers were taken into account, for their significant contribution of transporting the 
products to the extracellular space. Due to the rarity of transporters that possess the 
ability to transport the complex natural products, transporter engineering has been 
developed to improve the situation. For example, through protein engineering, one 
variant of AcrB from AcrAB-TolC efflux pump can effectively improve the α-pinene 
efflux out of the E. coli cell. However, because of unclear of the transport mecha-
nisms and lacking of crystal structures, the application of transporters in natural 
products is still limited.
In this chapter, the biosynthetic pathways of natural products and their recon-
struction in yeast cell factories were systematically summarized. The strategies 
developed to increase natural products productivity in yeast were also discussed 
including protein engineering, metabolic engineering, subcellular localization and 
fermentation control. With these endeavors, the engineered strains can produce 
these compounds in different levels. These achievements indicate yeast a promising 
chassis for the heterogeneous biosynthesis of natural products.
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